What is John Frangie?
John Frangie, M.D. operates as a premier ophthalmological center, specializing in high-precision procedures including cataract surgery, cornea transplants, and advanced LASIK techniques. Recognized as a Bausch and Lomb Center of Excellence, the practice distinguishes itself through the integration of cutting-edge medical technology and personalized patient care. By focusing on no-blade LASIK and sophisticated lens replacement, the firm has established a competitive moat in the elective vision correction market, serving a diverse patient demographic with high-acuity needs.
How much funding has John Frangie raised?
John Frangie has raised a total of $260K across 2 funding rounds:
Debt
$150K
Debt
$110K
Debt (2020): $150K with participation from PPP
Debt (2021): $110K led by PPP
Key Investors in John Frangie
PPP
Public-Private Partnership
What's next for John Frangie?
With the recent capital injection, the practice is well-positioned to accelerate its operational footprint and invest in next-generation diagnostic and surgical equipment. The strategic focus will likely shift toward enhancing patient throughput and expanding the reach of its specialized eye care services. As the firm matures, the integration of these financial resources will be critical in maintaining its status as a regional leader in ophthalmology, potentially facilitating further investment in clinical research and the adoption of emerging ocular technologies to drive long-term value.
See full John Frangie company page
